IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

NIGER, MONICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.829
EU - Europa 1.800
AS - Asia 1.524
SA - Sud America 170
Continente sconosciuto - Info sul continente non disponibili 154
AF - Africa 37
OC - Oceania 16
Totale 5.530
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.750
DE - Germania 841
CN - Cina 441
SG - Singapore 391
IT - Italia 268
BD - Bangladesh 250
GB - Regno Unito 222
HK - Hong Kong 146
BR - Brasile 141
SE - Svezia 99
VN - Vietnam 91
RU - Federazione Russa 84
FR - Francia 60
CA - Canada 56
IN - India 55
IE - Irlanda 52
NL - Olanda 49
FI - Finlandia 36
ID - Indonesia 26
TR - Turchia 25
JP - Giappone 23
CI - Costa d'Avorio 17
KR - Corea 16
ES - Italia 15
AT - Austria 13
AU - Australia 13
BE - Belgio 13
UA - Ucraina 12
AR - Argentina 11
PL - Polonia 10
PK - Pakistan 9
MX - Messico 8
ZA - Sudafrica 8
IQ - Iraq 6
TH - Thailandia 6
PH - Filippine 5
BO - Bolivia 4
CH - Svizzera 4
CO - Colombia 4
DK - Danimarca 4
IR - Iran 4
TW - Taiwan 4
EC - Ecuador 3
KE - Kenya 3
MA - Marocco 3
NO - Norvegia 3
NP - Nepal 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
AZ - Azerbaigian 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
HN - Honduras 2
HU - Ungheria 2
JM - Giamaica 2
KZ - Kazakistan 2
LB - Libano 2
MV - Maldive 2
PR - Porto Rico 2
PY - Paraguay 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CL - Cile 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
EG - Egitto 1
GE - Georgia 1
GF - Guiana Francese 1
GR - Grecia 1
GT - Guatemala 1
IL - Israele 1
IS - Islanda 1
JO - Giordania 1
KG - Kirghizistan 1
KN - Saint Kitts e Nevis 1
KW - Kuwait 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MO - Macao, regione amministrativa speciale della Cina 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
RO - Romania 1
SC - Seychelles 1
SN - Senegal 1
SV - El Salvador 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.377
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 762
Ashburn 278
Singapore 194
Southend 165
Chandler 130
Hong Kong 127
San Jose 107
Dallas 106
Fairfield 89
New York 72
Beijing 70
Los Angeles 60
Milan 56
Council Bluffs 55
Dublin 52
Santa Clara 52
Cambridge 49
Seattle 47
Woodbridge 44
Wilmington 40
Houston 37
Ho Chi Minh City 33
Princeton 33
Hanoi 31
Munich 28
Dearborn 27
Ann Arbor 26
Hefei 26
Bengaluru 24
Buffalo 24
Jakarta 24
Moscow 21
Helsinki 20
Istanbul 20
Phoenix 20
Guangzhou 18
Lauterbourg 18
Nanjing 18
Abidjan 17
Boardman 17
Rome 16
Toronto 16
Shanghai 15
Des Moines 14
Brussels 13
Tokyo 13
Naples 12
Cangzhou 11
Chicago 11
São Paulo 11
Columbus 10
Redwood City 10
The Dalles 10
Atlanta 8
London 8
Seoul 8
Shenyang 8
Tianjin 8
Turku 8
Fuzhou 7
Hangzhou 7
Orem 7
Warsaw 7
Zhengzhou 7
Amsterdam 6
Bexley 6
Falls Church 6
Grafing 6
Haikou 6
Montreal 6
Mountain View 6
Nuremberg 6
Ottawa 6
Palermo 6
Quanzhou 6
Rochester 6
San Diego 6
Silver Spring 6
Sydney 6
Vienna 6
Wuhan 6
Bari 5
Brescia 5
Central District 5
Changsha 5
Erlangen 5
Hyderabad 5
Jinan 5
Johannesburg 5
Oxford 5
Washington 5
Ascoli Piceno 4
Belo Horizonte 4
Berlin 4
Bologna 4
Brasília 4
Bühl 4
Denver 4
Eitensheim 4
Gainesville 4
Totale 3.470
Salva come PNG Salva come JPEG
Nome #
Prognostic impact of ATM mutations in patients with metastatic colorectal cancer 383
GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab : A clinical and translational study 354
Undetected toxicity risk in pharmacogenetic testing for dihydropyrimidine dehydrogenase 353
Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: the ARMANI phase III trial 349
Comparative Effectiveness of Gemcitabine plus Nab-Paclitaxel and FOLFIRINOX in the First-Line Setting of Metastatic Pancreatic Cancer: A Systematic Review and Meta-Analysis 349
Metronomic Capecitabine With Cyclophosphamide Regimen in Unresectable or Relapsed Pseudomyxoma Peritonei 300
Maintenance Therapy with Panitumumab Alone vs Panitumumab Plus Fluorouracil-Leucovorin in Patients with RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial 278
MGMT inactivation as a new biomarker in patients with advanced biliary tract cancers 277
Targeting the PI3K/AKT/mTOR pathway in biliary tract cancers: A review of current evidences and future perspectives 274
Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancer 269
Ramucirumab as Second-Line Therapy in Metastatic Gastric Cancer : Real-World Data from the RAMoss Study 246
Safety of long-term exposure to abiraterone acetate in patients with castration-resistant prostate cancer and concomitant cardiovascular risk factors 240
Management of BRCA Tumour Testing in an Integrated Molecular Tumour Board Multidisciplinary Model 223
BRAF in metastatic colorectal cancer : the future starts now 221
Preoperative Capecitabine, Oxaliplatin, and Irinotecan in Resectable Gastric or Gastroesophageal Junction Cancer: Pathological Response as Primary Endpoint and FDG-PET Predictions 217
FOLFOXIRI-Bevacizumab or FOLFOX-Panitumumab in Patients with Left-Sided RAS/BRAF Wild-Type Metastatic Colorectal Cancer: A Propensity Score-Based Analysis 206
A new nomogram for estimating survival in patients with brain metastases secondary to colorectal cancer 196
Prognostic Role of a New Index Tested in European and Korean Advanced Biliary Tract Cancer Patients: the PECS Index 196
Progress in treatments for colorectal cancer peritoneal metastases during the years 2010-2015 : a systematic review 186
Outpatient palliative care referral system (PCRS) for patients with advanced cancer: an impact evaluation protocol 159
Safety and antitumor activity of metformin plus lanreotide in patients with advanced gastro-intestinal or lung neuroendocrine tumors: the phase Ib trial MetNET2 158
The potential role of metformin in the treatment of patients with pancreatic neuroendocrine tumors: a review of preclinical to clinical evidence 92
null 3
null 1
Totale 5.530
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.205
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.205
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022239 0 10 11 23 18 18 9 18 19 34 14 65
2022/2023401 57 52 41 32 35 78 9 18 46 7 21 5
2023/2024765 7 14 17 25 88 22 106 105 53 103 114 111
2024/20251.042 95 111 85 121 57 48 79 64 40 98 82 162
2025/20261.931 186 144 177 114 136 90 215 57 157 118 266 271
2026/2027229 126 103 0 0 0 0 0 0 0 0 0 0
Totale 5.530